Patents by Inventor Angeline Goh

Angeline Goh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11945877
    Abstract: Antibodies, antigen-binding fragments and polypeptides that bind to HER2 are disclosed, as well as nucleic acids and vectors encoding the same. Also provided are cells comprising the antibodies, antigen-binding fragments, polypeptides, nucleic acids and vectors, methods of making such molecules, and the use of such molecules for therapeutic applications.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: April 2, 2024
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Lionel Jianrong Low, Angeline Goh, Sandy Wen-Hsin Lee
  • Patent number: 11912761
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: February 27, 2024
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Patent number: 11780913
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: October 10, 2023
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Patent number: 11702471
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: July 18, 2023
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Publication number: 20210155685
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 27, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I WANG, Angeline GOH, Siok Ping YEO, Alessandra Rosa MORTELLARO, Subhra Kumar BISWAS, Florent GINHOUX, Pingyu ZHONG
  • Publication number: 20210155686
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 27, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I WANG, Angeline GOH, Siok Ping YEO, Alessandra Rosa MORTELLARO, Subhra Kumar BISWAS, Florent GINHOUX, Pingyu ZHONG
  • Publication number: 20210139605
    Abstract: Antibodies, antigen-binding fragments and polypeptides that bind to HER2 are disclosed, as well as nucleic acids and vectors encoding the same. Also provided are cells comprising the antibodies, antigen-binding fragments, polypeptides, nucleic acids and vectors, methods of making such molecules, and the use of such molecules for therapeutic applications.
    Type: Application
    Filed: February 12, 2019
    Publication date: May 13, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Lionel Jianrong Low, Angeline Goh, Sandy Wen-Hsin Lee
  • Patent number: 10919962
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: February 16, 2021
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Rosa Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Publication number: 20210024627
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 28, 2021
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I WANG, Angeline GOH, Siok Ping YEO, Alessandra Rosa MORTELLARO, Subhra Kumar BISWAS, Florent GINHOUX, Pingyu ZHONG
  • Publication number: 20200071406
    Abstract: Antibodies and fragments thereof which bind to peptide-MHC complexes are described. In particular, an antibody binding to a peptide-MHC complex comprising a peptide of p53 and a MHC Class I molecule comprising ?-chain encoded by an HLA-A*24 allele is claimed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods of treating, preventing and diagnosing cancers using the same.
    Type: Application
    Filed: March 1, 2018
    Publication date: March 5, 2020
    Inventors: Cheng-I Wang, Lionel Low, Angeline Goh, Bei Wang, Wen-Hsin Lee, Ching-Wen Huang
  • Publication number: 20190144535
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: November 15, 2018
    Publication date: May 16, 2019
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-l Wang, Angeline Goh, Siok Ping Yeo, Alessandra Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Patent number: 10167335
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: January 1, 2019
    Assignee: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Mortellaro, Subhra Kumar Biswas, Florent Ginhoux, Pingyu Zhong
  • Publication number: 20150037248
    Abstract: The present invention is directed to antigen binding proteins and in particular to IL-1? antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
    Type: Application
    Filed: February 13, 2013
    Publication date: February 5, 2015
    Applicant: Agency for Science, Technology and Research
    Inventors: Cheng-I Wang, Angeline Goh, Siok Ping Yeo, Alessandra Mortellaro, Subhra Kumar, Florent Ginhoux, Pingyu Zhong